Report : Middle East & Africa Dermatology Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product Type (Treatment Device and Diagnostic Device), Application (Skin Care Diagnosis, Skin Rejuvenation, Hair Removal, Body Contouring & Skin Tightening, Psoriasis, and Others), and End User (Hospitals, Dermatology Clinics, and Others)
At 8.7% CAGR, the Middle East & Africa Dermatology Devices market is speculated to be worth US$ 344.88 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Middle East & Africa dermatology devices market was valued at US$ 208.66 million in 2022 and is expected to reach US$ 344.88 million by 2028, registering a CAGR of 8.7% from 2022 to 2028. Rising aesthetics procedures among individuals and technological advancement in dermatology devices are the critical factors attributed to the Middle East & Africa dermatology devices market expansion.
The majority skin cancers cases are of Nonmelanoma skin cancer (NMSCs), affecting more than 3 million Americans annually. Among these, women had the greatest incidence rates for NMSCs, with the rates increasing among the younger population. Additionally, the Frontiers S.A. report states that the prevalence of skin cancer is a global trend. Skin biopsy and histopathological evaluation are essential in confirming skin cancer. For example, the development of imaging technologies, methods, and devices intended for recording and analyzing have progressed rapidly. Dermoscopic imaging devices irradiate light onto the upper dermal layer to observe and record detailed pigment changes. Additionally, the development of high-resolution noninvasive diagnostic devices, such as confocal microscopy and multiphoton microscopy, that can detect cellular levels of skin lesions without biopsy have also been widely accepted in the market. Such innovative developments effectively help in receiving skin cancer diagnosis, accurate reading of changes in suspicious lesions, and the effectiveness of follow-up skin cancer surgery. Skin disorders is a major problem globally among teenagers and adults. Acne, Psoriasis, and Rosacea are among the most common skin disorders among the population. Diagnosis of such skin disorders can be effectively done by using Artificial Intelligence (AI). Such factors would offer lucrative opportunities for the Middle East & Africa dermatology devices market during 2022–2028.
On the contrary, complications after cancer procedural treatment and cosmetic surgery from unqualified professionals hurdles the growth of Middle East & Africa dermatology devices market.
Based on Product Type, the Middle East & Africa dermatology devices market is segmented into treatment device and diagnostic Device. The treatment device segment held 65.6% market share in 2022, amassing US$ 136.95 million. It is projected to garner US$ 227.75 million by 2028 to expand at 8.8% CAGR during 2022–2028.
Based on application, the Middle East & Africa dermatology devices market is segmented into skin cancer diagnosis, skin rejuvenation, hair removal, body contouring & skin tightening, psoriasis, and others. With 34.3% share of the domain, the skin cancer diagnosis segment dominated the market in 2022. It accrued US$ 71.64 million in 2022 and is estimated to generate US$ 122.23 million by 2028 to grow at a CAGR of 9.3% over the forecast period.
Based on end user, the Middle East & Africa dermatology devices market is segmented into hospitals, dermatology clinics, and others. The hospitals segment held the largest share of the market in 2022. With 57.7% share of the domain, the hospitals segment dominated the market in 2022. It accrued US$ 120.37 million in 2022 and is estimated to generate US$ 197.57 million by 2028 to grow at a CAGR of 12.0% over the forecast period.
Based on country, the Middle East & Africa dermatology devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 35.9% of the Middle East & Africa dermatology devices market share in 2022. It was assessed at US$ 74.93 million in 2022 and is likely to hit US$ 128.16 million by 2028, exhibiting a CAGR of 9.4% during the forecast period.
Key players dominating the Middle East & Africa dermatology devices market are Alma Lasers, Candela Corporation, Cutera Inc., El.En. S.p.A., FotoFinder Systems GmbH, Leica Microsystems, and Lumenis, among others.
Contact Person: Sameer Joshi
Email Id: email@example.com